Jinhe Biotechnology Management
Management criteria checks 4/4
Jinhe Biotechnology's CEO is Changxian Xie, appointed in Nov 2007, has a tenure of 17.42 years. directly owns 0.44% of the company’s shares, worth CN¥21.22M. The average tenure of the management team and the board of directors is 10.8 years and 10.5 years respectively.
Key information
Changxian Xie
Chief executive officer
CN¥575.9k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 17.4yrs |
| CEO ownership | 0.4% |
| Management average tenure | 10.8yrs |
| Board average tenure | 10.5yrs |
Recent management updates
Recent updates
Sentiment Still Eluding Jinhe Biotechnology CO., LTD. (SZSE:002688)
Mar 27
Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10
May 27Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%
May 13Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
May 13CEO
Changxian Xie (62 yo)
17.4yrs
Tenure
CN¥575,900
Compensation
Mr. Changxian Xie serves as General Manager at Jinhe Biotechnology CO., LTD. since November 27, 2007 and serves as its Director since November 27, 2007.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 17.4yrs | CN¥575.90k | 0.44% CN¥ 21.2m | |
| Financial Director | 10.7yrs | CN¥306.50k | 0.040% CN¥ 1.9m | |
| Deputy GM & Director | 11yrs | CN¥696.00k | no data | |
| Deputy GM & Non-Independent Director | 1.9yrs | CN¥305.90k | 0.040% CN¥ 1.9m | |
| Board Secretary & Director | 4.1yrs | CN¥394.80k | 1% CN¥ 48.9m | |
| Deputy General Manager | 11yrs | CN¥246.10k | no data | |
| Deputy General Manager | 14.3yrs | CN¥307.80k | 0.084% CN¥ 4.1m | |
| Deputy General Manager | 8.3yrs | CN¥308.90k | 0.040% CN¥ 1.9m | |
| Chief Accounting Officer | no data | no data | no data |
10.8yrs
Average Tenure
55yo
Average Age
Experienced Management: 002688's management team is seasoned and experienced (10.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 17.4yrs | CN¥575.90k | 0.44% CN¥ 21.2m | |
| Deputy GM & Director | 11yrs | CN¥696.00k | no data | |
| Deputy GM & Non-Independent Director | 1.9yrs | CN¥305.90k | 0.040% CN¥ 1.9m | |
| Board Secretary & Director | 1.9yrs | CN¥394.80k | 1% CN¥ 48.9m | |
| Chairman | 17.4yrs | CN¥880.50k | 31.96% CN¥ 1.6b | |
| Vice Chairman of Board of Directors | 17.4yrs | CN¥610.00k | 0.68% CN¥ 33.2m | |
| Chairman of the Supervisory Board | 9.9yrs | no data | no data | |
| Shareholder Representative Supervisor | 11yrs | no data | no data | |
| Employee Representative Supervisor | 11.1yrs | no data | no data | |
| Independent Director | 4.9yrs | CN¥82.80k | no data | |
| Independent Director | 4.9yrs | CN¥82.80k | no data | |
| Independent Director | 4.9yrs | CN¥82.80k | no data |
10.5yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 002688's board of directors are seasoned and experienced ( 10.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/28 15:42 |
| End of Day Share Price | 2025/04/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jinhe Biotechnology CO., LTD. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xie Zhiyou | China Galaxy Securities Co., Ltd. |
| Sha Zhou | China Merchants Securities Co. Ltd. |